ACX
ActiveNext-generation biocides for sustainable agriculture at scale
This company has previously operated under “AcX Therapeutics”, “AcX”. A rename frequently marks a pivot in positioning or product — useful raw material for variant ideas.
About
ACX is developing a new standard for precision agriculture technologies by providing sustainable, eco-friendly alternatives to chemical pesticides. Our mission is to transform agriculture through sustainable biological crop protection that increases yields while safeguarding the environment, farmers, and consumers.
Founders · 2
Emmanouela is the Co-Founder & CEO of ACX and PhD in Biochemistry and Biophysics from the University of Cambridge. Previously, she held several research positions working in immunology, cancer, malaria vaccine development and viral drug discovery (in institutes like Barts Cancer Institute CRUK, Cambridge University, King’s College London, Institute Curie France and Imperial College London).
Melina is the Co-founder & CTO of ACX and PhD in Computer Science from King's College London. Previously, she held several research positions spanning digital health, robotics, technology-enable interventions, HCAI and NLP (in institutes like Cambridge University, King’s College London, National Health Service (NHS) in England and Francis Crick Institute).
Related startups
Making Next-Generation Antibiotics that Outpace Bacterial Evolution
AI-driven HVAC control system for improved energy performance
